| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |